Anatara Lifesciences Ltd (ASX:ANR) Chief Executive Officer Appointment
Anatara Lifesciences (ASX:ANR) is pleased to announce that it has appointed Mr Steven Lydeamore as Chief Executive Officer, effective as of 3rd December 2018.
Anatara Lifesciences (ASX:ANR) is pleased to announce that it has appointed Mr Steven Lydeamore as Chief Executive Officer, effective as of 3rd December 2018.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming that it has been issued a sales licence by Health Canada.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce that it has invested CAD$2.5 million of equity into privately-held Embark Health Inc. This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%*.
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ") is pleased to announce that it has made a cornerstone equity investment of USD$1 million for an 18.2% shareholding in privately-held VitaGenne Inc.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract.
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ") is pleased to note the attached release confirming that Fire & Flower Inc. ("Fire & Flower") has raised CAD$36.5 million, above its original target of CAD$30 million, from equity instruments ahead of its proposed listing on the TSX Venture Exchange ("TSX-V").
The Hydroponics Company Limited, to be renamed THC Global Group Limited (subject to shareholder approval), (ASX:THC) (OTCMKTS:HDRPF) has commenced supply of Endoca CBD products to its first Australian patients.